Cellebrite files Form 144 for 1,045 vested RSUs

Cellebrite DI Ltd. filed a Form 144 reporting a proposed resale of 1,045 ordinary shares as vested Restricted Share Units under an S-8 registered plan on 05/11/2026.

Rhea-AI Filing Summary

Cellebrite DI Ltd. filed a Form 144 reporting a proposed resale of 1,045 ordinary shares as vested Restricted Share Units under an S-8 registered plan on 05/11/2026. The filing also lists recent open-market sales by Marcus Jewell of 1,779, 13,276, and 4,613 ordinary shares with trade dates in 02/2026.

Insights

Securities Compliance Analyst

Form 144 notices a small resale of vested RSUs and records recent insider sales.

The filing lists 1,045 ordinary shares described as "Restricted Share Units Vested Under an Issuer S-8 Registered Plan" with a 05/11/2026 vesting date. The document separately records three sales by an individual, with trade dates in 02/2026.

Cash‑flow treatment and whether the resale is immediate or conditional are not stated; subsequent filings or broker reports would show execution details and settlement. Filings like this are routine notices under resale rules and typically reflect planned employee or affiliate dispositions.

Key Figures

Vested RSUs to be resold: 1,045 shares Sale reported (example 1): 1,779 shares Sale reported (example 2): 13,276 shares +2 more

5 metrics

Vested RSUs to be resold 1,045 shares Restricted Share Units vested under an issuer S-8 plan on <date>05/11/2026</date>

Sale reported (example 1) 1,779 shares Trade date <date>02/12/2026</date>, adjacent numeric value 24,201.55 shown

Sale reported (example 2) 13,276 shares Trade date <date>02/17/2026</date>, adjacent numeric value 188,172.17 shown

Sale reported (example 3) 4,613 shares Trade date <date>02/18/2026</date>, adjacent numeric value 65,221.36 shown

Listed numeric field 249,746,054 Numeric value appearing in the header row with date <date>05/12/2026</date>

Key Terms

Restricted Share Units, S-8 Registered Plan, Form 144

3 terms

Restricted Share Units financial

"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

S-8 Registered Plan regulatory

"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cellebrite (CLBT) report on Form 144?

The filing reports a proposed resale of 1,045 ordinary shares from vested RSUs under an S-8 plan on 05/11/2026. It also lists recent sales by an affiliate with trade dates in 02/2026.

How many shares vested under the S-8 plan in the CLBT filing?

The filing shows 1,045 shares described as Restricted Share Units that vested under an issuer S-8 registered plan on 05/11/2026. The item is presented as securities to be sold.

Who reported sales in the past three months in the CLBT Form 144?

The filing records three sales by Marcus Jewell dated in 02/2026, totaling reported transactions of 1,779, 13,276, and 4,613 ordinary shares respectively, with amounts shown alongside each trade.

Does the Form 144 show proceeds or currency for the reported sales?

The filing lists numeric values adjacent to each sale line (for example, 24,201.55 next to the 1,779 share line) but does not label a currency in the excerpt. The document shows the numbers as reported without currency specification.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/12/2026 - 06:15 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001875661
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CELLEBRITE DI LTD.
SEC File Number	001-40772
Address of Issuer	94 SHLOMO SHMELZER ROAD PETAH TIKVA ISRAEL 4970602
Phone	972-73-394-8000
Name of Person for Whose Account the Securities are To Be Sold	MARCUS JEWELL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares, par value NIS 0.00001	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	383	4998.15	249746054	05/12/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares, par value NIS 0.00001	05/11/2026	Restricted Share Units Vested Under an Issuer S-8 Registered Plan	Cellebrite DI Ltd.			1045	05/11/2026	Employee compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marcus Jewell 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Ordinary shares, par value NIS 0.00001	02/12/2026	1779	24201.55
Marcus Jewell 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Ordinary shares, par value NIS 0.00001	02/17/2026	13276	188172.17
Marcus Jewell 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Ordinary shares, par value NIS 0.00001	02/18/2026	4613	65221.36

144: Remarks and Signature

Remarks	The reporting person sold the securities reported herein on 05/12/2026 pursuant to a mandatory, non-discretionary, sell-to-cover arrangement for the purposes of satisfying income tax liabilities incurred upon vesting of restricted share unit awards only.
Date of Notice	05/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Marcus Jewell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)